Organization: McGill University

Human genome editing is not safe for clinical use, but nations must prepare: Report

A highly anticipated report says heritable genome editing, using tools like CRISPR to create edits that can be passed down to future generations, is not yet safe enough for clinical use. But it also provides specific guidance on how nations should prepare for the eventual use of CRISPR or other gene editing tools, defining a translational pathway from research to the clinic.

The Short Report – May 27, 2020: DMZ and Ryerson Futures merge; Canadian psychedelic research gets boost; CFI launches $25-million competition; progress on a homegrown COVID-19 vaccine; and more

The Natural Sciences and Engineering Research Council has awarded $76 million for 128 new applied research projects at colleges, cégeps and polytechnics. Funded through the tri-agency College and Community Innovation Program and the College-Industry Innovation Fund from the Canada Foundation for Innovation, the investments will connect colleges with local companies, particularly small- and medium-sized enterprises, to collaborate on projects that further…

The Short Report, May 6, 2020: AbCellera receives $175.6M for COVID-19 therapies; Canada contributes $850 million to global pandemic response; new “super angel” fund launches; and more

Vancouver-based AbCellera Biologics will receive up to $175.6 million from the federal Strategic Innovation Fund to fast-track antibody therapies against COVID-19. The funding will also go to build a first-of-its-kind antibody manufacturing facility over the next four years to help Canada respond to future pandemics. AbCellera has partnered with global biopharmaceutical company Eli Lilly to…